Effective de novo drug design is a long-standing but elusive goal for computational chemistry.
GastroPlus® Newsletter September 2023
Increasing the probability of success in clinical trials
GastroPlus® Newsletter August 2023
Quickening the pace of drug discovery with AI
GastroPlus® Newsletter July 2023
Expanding our Immunology and Oncology Drug Development Capabilities
Workshops and Webinars
Explore modeling and simulation summer school opportunities inside
Happy Spring… even though this year I have experienced the most severe case of “hay fever” ever.
Early Drug Discovery Application, FIH Predictions Workshops, and new software & consulting bundles
Happy Spring! (for those of us that are North of the Equator)
PBPK Summer Camp, FIH Predictions Workshops, and in-person conferences
Daylight savings time is back, so spring and warm weather are not far off!
MIDD+ 2023 sessions are now available for playback in our Resource Center
Exciting news from the world of GastroPlus®!
“The integration of our industry-leading ADMET Predictor and GastroPlus® mechanistic PBPK simulations into the initial generative chemical design process is what sets us apart from other machine learning drug design companies,” says AIDD Principal Scientist and former City of Hope Professor Jeremy Jones. “Our platform offers everything a medicinal chemist would want, at incredible speed.”
Simulations Plus is excited to announce that we are the recipients of a Comparably Award for “Best Company for Women” in 2022.